Kamil Onder
Overview
Explore the profile of Kamil Onder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
495
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Budreviciute A, Damiati S, Sabir D, Onder K, Schuller-Goetzburg P, Plakys G, et al.
Front Public Health
. 2020 Dec;
8:574111.
PMID: 33324597
Non-communicable diseases (NCDs) are of increasing concern for society and national governments, as well as globally due to their high mortality rate. The main risk factors of NCDs can be...
2.
Katileviciute A, Plakys G, Budreviciute A, Onder K, Damiati S, Kodzius R
Biomolecules
. 2019 Dec;
9(12).
PMID: 31861140
Recently more consideration has been given to the use of renewable materials and agricultural residues. Wheat production is increasing yearly and correspondingly, the volume of by-products from the wheat process...
3.
Baaity Z, Breunig S, Onder K, Somogyvari F
BMC Res Notes
. 2019 Nov;
12(1):720.
PMID: 31675990
Objective: We aim to directly detect Mycoplasma DNA in a U937 suspension cell culture without using DNA purification. In order to make Mycoplasma contamination monitoring easier, we optimized a commercially...
4.
Jacobi N, Seeboeck R, Hofmann E, Schweiger H, Smolinska V, Mohr T, et al.
Oncotarget
. 2018 Jan;
8(64):107423-107440.
PMID: 29296175
Complex three-dimensional (3D) models that recapitulate human tumor biology are essential to understand the pathophysiology of the disease and to aid in the discovery of novel anti-cancer therapies. 3D organotypic...
5.
Hundsberger H, Onder K, Schuller-Gotzburg P, Virok D, Herzog J, Rid R
BMC Genomics
. 2017 Jun;
18(1):450.
PMID: 28595602
Background: Recombinant peptide chips could constitute a versatile complementation to state-of-the-art in situ (chemical on-chip) synthesis, particle-based printing, or pre-manufactured peptide spotting. Bottlenecks still impeding a routine implementation - from...
6.
Virok D, Eszik I, Mosolygo T, Onder K, Endresz V, Burian K
J Virol Methods
. 2017 Jan;
242:46-52.
PMID: 28093274
Herpes simplex viruses (HSV) are common human pathogens that can cause painful but benign manifestations and recurrent complaints, but can also cause significant morbidity and mortality on infection of the...
7.
Al-Harthy T, Zoghaib W, Pfluger M, Schopel M, Onder K, Reitsammer M, et al.
Molecules
. 2016 Oct;
21(10).
PMID: 27689973
To design new compounds suitable as starting points for anticancer drug development, we have synthesized a novel series of benzoxazoles with pharmaceutically advantageous piperazine and fluorine moieties attached to them....
8.
Volk K, Breunig S, Rid R, Herzog J, Brauer M, Hundsberger H, et al.
Biol Chem
. 2016 Jul;
398(1):125-133.
PMID: 27467752
Method: Enzymol. 459, 395-433; Halavaty, A.S., Kim, Y., Minasov, G., Shuvalova, L., Dubrovska, I., Winsor, J., Zhou, M., Onopriyenko, O., Skarina, T., Papazisi, L., et al. (2012). Structural characterization and...
9.
Koller A, Rid R, Beyreis M, Bianchini R, Holub B, Lang A, et al.
Neuropeptides
. 2016 Jan;
56:83-8.
PMID: 26725588
Galanin and its receptors (GAL1, GAL2, GAL3) modulate a range of neuronal, immune and vascular activities. In vivo administration of SNAP 37889 (1-phenyl-3-[[3-(trifluoromethyl)phenyl]imino]-1H-indol-2-one), a potent small non-peptidergic antagonist of GAL3,...
10.
Herzog J, Rid R, Wagner M, Hundsberger H, Eger A, Bauer J, et al.
BMC Res Notes
. 2015 Dec;
8:785.
PMID: 26666517
Background: To be able to develop effective therapeutics for epidermolysis bullosa simplex (EBS), it is necessary to elucidate the molecular pathomechanisms that give rise to the disease's characteristic severe skin-blistering...